ReP USP - Resultado da busca

Artigo de periodico
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2024)
Matuozzo, Daniela ; Talouarn, Estelle ; Marchal, Astrid; Manry, Jeremy; Seeleuthner, Yoann; Zhang, Yu; Bolze, Alexandre ; Chaldebas, Matthieu; Condino Neto, Antonio ; Zatz, Mayana
Source: Genome Medicine. Unidades: IB, ICB
Subjects: IMUNOLOGIA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATUOZZO, Daniela et al. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, v. 16, 2024Tradução . . Disponível em: https://doi.org/10.1186/s13073-023-01173-8. Acesso em: 13 nov. 2024.
APA
Matuozzo, D., Talouarn, E., Marchal, A., Manry, J., Seeleuthner, Y., Zhang, Y., et al. (2024). Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, 16. Recuperado de https://doi.org/10.1186/s13073-023-01173-8
NLM
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2024 ; 16[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Vancouver
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2024 ; 16[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Artigo de periodico
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023)
Matuozzo, Daniela ; Talouarn, Estelle ; Marchal, Astrid; Manry, Jeremy; Seeleuthner, Yoann; Zhang, Yu; Bolze, Alexandre ; Chaldebas, Matthieu; Condino Neto, Antonio ; Zatz, Mayana
Source: Genome Medicine. Unidades: IB, ICB
Subjects: IMUNOLOGIA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATUOZZO, Daniela et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, v. 15, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13073-023-01173-8. Acesso em: 13 nov. 2024.
APA
Matuozzo, D., Talouarn, E., Marchal, A., Manry, J., Seeleuthner, Y., Zhang, Y., et al. (2023). Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, 15, 1-25. doi:10.1186/s13073-023-01173-8
NLM
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2023 ; 15 1-25.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Vancouver
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2023 ; 15 1-25.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Artigo de periodico
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency (2023)
Voyer, Tom Le ; Parent, Audrey V ; Liu, Xian ; Cederholm, Axel ; Condino Neto, Antonio ; Vidigal, Mateus; Zatz, Mayana
Source: Nature. Unidades: ICB, IB
Subjects: AUTOANTICORPOS, IMUNOLOGIA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VOYER, Tom Le et al. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. Nature, v. 623, p. 803–813, 2023Tradução . . Disponível em: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x. Acesso em: 13 nov. 2024.
APA
Voyer, T. L., Parent, A. V., Liu, X., Cederholm, A., Condino Neto, A., Vidigal, M., & Zatz, M. (2023). Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. Nature, 623, 803–813. doi:10.1038/s41586-023-06717-x
NLM
Voyer TL, Parent AV, Liu X, Cederholm A, Condino Neto A, Vidigal M, Zatz M. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency [Internet]. Nature. 2023 ; 623 803–813.[citado 2024 nov. 13 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x
Vancouver
Voyer TL, Parent AV, Liu X, Cederholm A, Condino Neto A, Vidigal M, Zatz M. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency [Internet]. Nature. 2023 ; 623 803–813.[citado 2024 nov. 13 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x
Artigo de periodico
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022)
Manry, Jérémy; Bastard, Paul ; Gervais, Adrian; Voyer, Tom Le; Rosain, Jérémie ; Philippot, Quentin; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich; Eto, Shohei; Condino Neto, Antonio ; Zatz, Mayana
Source: Proceedings of the National Academy of Sciences. Unidades: ICB, IB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRY, Jérémy et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proceedings of the National Academy of Sciences, v. 119, n. 21, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1073/pnas.2200413119. Acesso em: 13 nov. 2024.
APA
Manry, J., Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., et al. (2022). The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proceedings of the National Academy of Sciences, 119( 21), 1-10. doi:10.1073/pnas.2200413119
NLM
Manry J, Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Michailidis E, Hoffmann H-H, Eto S, Condino Neto A, Zatz M. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies [Internet]. Proceedings of the National Academy of Sciences. 2022 ; 119( 21): 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1073/pnas.2200413119
Vancouver
Manry J, Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Michailidis E, Hoffmann H-H, Eto S, Condino Neto A, Zatz M. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies [Internet]. Proceedings of the National Academy of Sciences. 2022 ; 119( 21): 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1073/pnas.2200413119
Artigo de periodico
Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes (2021)
Naslavsky, Michel ; Castro, Mateus Vidigal de ; Matos, Larissa do Rêgo Barros; Cória, Vivian Romanholi ; Batista Junior, Pedro Benedito; Razuk, Álvaro; Saldiva, Paulo Hilário Nascimento ; Dolhnikoff, Marisa ; Ferreira, Laire Schidlowski ; Prando, Carolina ; Cunha Neto, Edécio ; Condino Neto, Antonio ; Passos-Bueno, Maria Rita ; Zatz, Mayana
Source: Genetics and Molecular Biology. Unidades: IB, FM, ICB
Subjects: GENÔMICA, IMUNOLOGIA, COVID-19, INFECÇÕES POR VÍRUS DE RNA, INFECÇÕES POR CORONAVIRUS, HOSPEDEIRO IMUNOCOMPROMETIDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASLAVSKY, Michel et al. Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes. Genetics and Molecular Biology, v. 44, n. 1, p. 8 , 2021Tradução . . Disponível em: https://doi.org/10.1590/1678-4685-gmb-2020-0302. Acesso em: 13 nov. 2024.
APA
Naslavsky, M., Castro, M. V. de, Matos, L. do R. B., Cória, V. R., Batista Junior, P. B., Razuk, Á., et al. (2021). Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes. Genetics and Molecular Biology, 44( 1), 8 . doi:10.1590/1678-4685-gmb-2020-0302
NLM
Naslavsky M, Castro MV de, Matos L do RB, Cória VR, Batista Junior PB, Razuk Á, Saldiva PHN, Dolhnikoff M, Ferreira LS, Prando C, Cunha Neto E, Condino Neto A, Passos-Bueno MR, Zatz M. Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes [Internet]. Genetics and Molecular Biology. 2021 ; 44( 1): 8 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1678-4685-gmb-2020-0302
Vancouver
Naslavsky M, Castro MV de, Matos L do RB, Cória VR, Batista Junior PB, Razuk Á, Saldiva PHN, Dolhnikoff M, Ferreira LS, Prando C, Cunha Neto E, Condino Neto A, Passos-Bueno MR, Zatz M. Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes [Internet]. Genetics and Molecular Biology. 2021 ; 44( 1): 8 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1678-4685-gmb-2020-0302
Artigo de periodico-carta/editorial
Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Su, Helen C. ; Casanova, Jean-Laurent ; Spaan, András N. ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41590-021-01096-9. Acesso em: 13 nov. 2024. , 2021
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41590-021-01096-9
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 13 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 13 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice (2017)
Nunes, Bruno Ghirotto ; Loures, Flavio Vieira ; Bueno, Heloisa Maria Siqueira ; Cangussu, Erica Baroni; Goulart, Ernesto ; Coatti, Giuliana Castello ; Caldini, EliaTamaso Espin Garcia ; Condino Neto, Antonio ; Zatz, Mayana
Source: European Journal of Human Genetics. Unidades: FM, ICB, IB
Subjects: IMUNOLOGIA, SISTEMA IMUNE, IMUNOGLOBULINAS, DOENÇAS AUTOIMUNES, CAMUNDONGOS, FENÓTIPOS, DISTROFIA MUSCULAR, MUTAÇÃO GENÉTICA, CITOCINAS, SECREÇÃO, CÉLULAS DENDRÍTICAS, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Bruno Ghirotto et al. Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice. European Journal of Human Genetics, v. 25, n. 12, p. 1388-1396, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41431-017-0017-y. Acesso em: 13 nov. 2024.
APA
Nunes, B. G., Loures, F. V., Bueno, H. M. S., Cangussu, E. B., Goulart, E., Coatti, G. C., et al. (2017). Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice. European Journal of Human Genetics, 25( 12), 1388-1396. doi:10.1038/s41431-017-0017-y
NLM
Nunes BG, Loures FV, Bueno HMS, Cangussu EB, Goulart E, Coatti GC, Caldini ETEG, Condino Neto A, Zatz M. Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice [Internet]. European Journal of Human Genetics. 2017 ; 25( 12): 1388-1396.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41431-017-0017-y
Vancouver
Nunes BG, Loures FV, Bueno HMS, Cangussu EB, Goulart E, Coatti GC, Caldini ETEG, Condino Neto A, Zatz M. Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice [Internet]. European Journal of Human Genetics. 2017 ; 25( 12): 1388-1396.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41431-017-0017-y
Artigo de periodico
Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity (2017)
Schimke, Lena F; Hibbard, James; Martinez-Barricarte, Ruben; Khan, Taj Ali; Cavalcante, Ricardo de Souza; Oliveira-Junior, Edgar Borges de; França, Tábata Takahashi; Iqbal, Asif; Yamamoto, Guilherme; Arslanian, Christina; Feriotti, Claudia; Costa, Tânia Alves; Bustamante, Jacinta; Boisson-Dupuis, Stéphanie; Casanova, Jean-Laurent; Barbuto, José Alexandre Marzagão ; Zatz, Mayana ; Mendes, Rinaldo Poncio; Calich, Vera Lúcia Garcia; Ochs, Hans D; Torgerson, Troy R; Cabral-Marques, Otavio; Condino Neto, Antonio
Source: Journal of Infectious Diseases. Unidades: ICB, IB
Subjects: PARACOCCIDIOIDOMICOSE, IMUNOLOGIA, MUTAÇÃO GENÉTICA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, INFECÇÕES BACTERIANAS E MICOSES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHIMKE, Lena F et al. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity. Journal of Infectious Diseases, v. 216, n. 12, p. 1623-1634, 2017Tradução . . Disponível em: https://doi.org/10.1093/infdis/jix522. Acesso em: 13 nov. 2024.
APA
Schimke, L. F., Hibbard, J., Martinez-Barricarte, R., Khan, T. A., Cavalcante, R. de S., Oliveira-Junior, E. B. de, et al. (2017). Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity. Journal of Infectious Diseases, 216( 12), 1623-1634. doi:10.1093/infdis/jix522
NLM
Schimke LF, Hibbard J, Martinez-Barricarte R, Khan TA, Cavalcante R de S, Oliveira-Junior EB de, França TT, Iqbal A, Yamamoto G, Arslanian C, Feriotti C, Costa TA, Bustamante J, Boisson-Dupuis S, Casanova J-L, Barbuto JAM, Zatz M, Mendes RP, Calich VLG, Ochs HD, Torgerson TR, Cabral-Marques O, Condino Neto A. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity [Internet]. Journal of Infectious Diseases. 2017 ; 216( 12): 1623-1634.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/infdis/jix522
Vancouver
Schimke LF, Hibbard J, Martinez-Barricarte R, Khan TA, Cavalcante R de S, Oliveira-Junior EB de, França TT, Iqbal A, Yamamoto G, Arslanian C, Feriotti C, Costa TA, Bustamante J, Boisson-Dupuis S, Casanova J-L, Barbuto JAM, Zatz M, Mendes RP, Calich VLG, Ochs HD, Torgerson TR, Cabral-Marques O, Condino Neto A. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity [Internet]. Journal of Infectious Diseases. 2017 ; 216( 12): 1623-1634.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/infdis/jix522

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration